PharmAsia News brings you a look at Turkey’s drug market by capturing recent moves by international and domestic firms.

A PharmAsia News update shows Turkey has set a target to domestically manufacture 60% of the drug products used annually and 20% of medical device and equipment by an unspecified timeframe. The government also moved to offer more support into R&D for high-value biopharmaceutical products and sent a large ministerial delegation to the annual Bio Conference in San Diego as a signal of how important the sector is to its public health programs.

A PharmAsia News update on Turkish biomedical regulatory policies, including reports that the government offered industry to keep discount rates secret and an 11.7% jump in exports in the first four months of 2014.

A PharmAsia News update on Turkish biomedical regulatory policies, including a penicillin shortage and an update on a draft patent law.